Neural Induction
Timed exposer to LDN193189/SB431542 (day 0-5), Shh/FGF8 (day 1-7), LDN193189 alone (day [5] [6] [7] [8] [9] [10] [11] , CHIR99021 (day [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] . Cells grown on matrigel in KSR (DMEM, KSR, L-Glu, β-Me) for 11d. KSR media switched to N2 media on day 5. Day 11 media switched to Neurobasal/B27/L-Glu medium (supp. CHIR [until d13 ], BDNG, ascorbic acid, GDNF, TGFβ3, dibutyryl cAMP, DAPT) for 9d.
Neuronal Differentiation/Time
Cells lifted via accutase and replated on polyornithine/laminin/fibronectin on day 20 in differentiation medium (NB/B27+BDNF, ascorbic acid, GDNF, dbcAMP, TGFβ3, DAPT) until maturation. Total time 20d.
Phenotype
Differentiated neurons from SNCA-tri patient secrete higher levels alpha-synuclein compared to control neurons. 5-day co-cultures SNCA-tri neurons and N2a cells with restricted cell-to-cell contact showed alpha-synuclein puncta around and within the N2a cells. Alpha-synuclein mRNA and protein levels were reduced in CRISPR-edited isogenic iPSC clones (2 functional SNCA gene copies). SNCA-tri has little effect on neuronal differentiation based on RNA-Seq. 90-fold overexpression of SNCA mRNA in SNCA-tri neurons were restored in isogenic controls. The three branches of UPR were upregulated in AST neurons. SNCA-tri showed ER stress phenotype, induction of IRE1a/XBP1 axis (unfolded protein response (UPR)) and UPR activation.
(Mittal et al., 2017)
iPSC Source iPSC-derived NPCs: 1 patient (SNCA triplication, 42 yrs male), 1 healthy control (46 yrs female sibling) (Flierl et al., 2014) iPSC Reprogramming/Number of clones
Maintenance/Passaging
On iMEF cells + Geltrex in (DMEM/F12, 20% KSO, NEAA, β-ME, FGF2)/Mechanical and enzymatic, Coll/ Disp. Accutase passaging.
Neural Induction
EB suspension culture for 4d in EB medium (hESC, -FGF2 +/-Dorsomorphine, SB431542). 2-3d in NIM (DMEM/F12, NEAA, N2, FGF2) feeder free. Manual rosette isolation and feeder free culture with enzymatic passaging in NPC media (Neurobasal, B27, NEAA, FGF2),PSA-NCAM sorting 4 . Total time 7d.
Neuronal Differentiation/Time
N/A Phenotype Beta-adrenoreceptor agonist clenbuterol reduces alpha-synuclein expression by 20% in SNCA-tri NPCs. Clenbuterol reduces mitochondria-associated superoxide in SNCA-tri and positively affects viability when exposed to rotenone. Alpha-synuclein downregulation by beta-adrenoreceptor agonists was shown to be mediated by a decrease in H3K27 acetylation in promoter and intron 4 enhancers of the SNCA gene. (Chung et al., 2013) iPSC Source iPSCs (SNCA, p.A53T (female, AAO 49yrs, (Golbe et al., 1996; Soldner et al., 2011) ) and SNCA triplication (Byers et al., 2011) 
SNCA Point Mutations

